ArticleCancer prevention research (Philadelphia, Pa.)2021
Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States.
Article in Cancer prevention research (Philadelphia, Pa.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.
- Intergroup statement: opportunistic salpingectomy-molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss).Archives of gynecology and obstetrics · 2025Guideline
- Pooled it
- Physician-level variability in adopting opportunistic salpingectomy for ovarian cancer prevention at the time of hysterectomy.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2026Article
- Peer influence on physicians in adopting opportunistic salpingectomy at the time of hysterectomy.American journal of obstetrics and gynecology · 2025Article
- Physician variation in adopting opportunistic salpingectomy at the time of postpartum and interval sterilization for ovarian cancer risk reduction.Gynecologic oncology · 2025Article
- Opportunistic salpingectomy for prevention of ovarian cancer among the general population.Current opinion in obstetrics & gynecology · 2025Review
- Physician Peer Influence on Salpingectomy Uptake for Tubal Sterilization and Ovarian Cancer Prevention.JAMA network open · 2025Article
- Gauging the Magnitude of Missed Opportunity for Ovarian Cancer Prevention.JAMA surgery · 2025Article
- Ovarian cancer risk reduction by salpingectomy during non-gynaecological surgery: scoping review.BJS open · 2024Article
- Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs.Current oncology (Toronto, Ont.) · 2023Review
- Prevention of Epithelial Ovarian Cancer.Cold Spring Harbor perspectives in medicine · 2023Review
- Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany.Journal of cancer research and clinical oncology · 2023Article
- Timeliness of diagnostic evaluation for postmenopausal bleeding: A retrospective cohort study using claims data.PloS one · 2023Article
- Possible Association of Hysterectomy Accompanied with Opportunistic Salpingectomy with Early Menopause: A Retrospective Cohort Study.International journal of environmental research and public health · 2022Article
- Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.American journal of obstetrics and gynecology · 2022Article
- Assessment of Perceptions and Practices in Primary Care Providers Regarding Opportunistic Salpingectomy.Journal of primary care & community healthArticle
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Evidence suggesting that high-grade serous ovarian cancers originate in the fallopian tubes has led to the emergence of opportunistic salpingectomy (OS) as an approach to reduce ovarian-cancer risk. In the U.S., some national societies now recommend OS in place of tubal ligation for sterilization or during a benign hysterectomy in average-risk women. However, limited data exist on the dissemination of OS in clinical practice. We examined the uptake and predictors of OS in a nationwide sample of inpatient and outpatient claims (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.